Physician profile
Daniel J Barbaro
NPI 1669447157
$43,716.76
in general payments reported to CMS, 2019-2025
16 companies · $5,976 in 2025
The $5,976 reported for 2025 was more than what 91% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $163 · 2021: $921 · 2022: $11K · 2023: $921 · 2024: $11K · 2025: $5,976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,900 · Food and Beverage: $4,723 · Travel and Lodging: $3,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,900.00 |
| Food and Beverage | $4,722.98 |
| Travel and Lodging | $3,598.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cepheid | $42,823.12 | 2019-2025 | Genexpert, Xpert Mrsa Nxg |
| Insmed, INC. | $203.96 | 2019-2020 | |
| Viiv Healthcare Company | $145.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $125.00 | 2019 | |
| Gilead Sciences, INC. | $120.11 | 2019-2023 | Veklury |
| Allergan, INC. | $60.76 | 2019-2020 | |
| Janssen Biotech, INC. | $58.72 | 2019-2020 | |
| Angiodynamics, INC. | $36.69 | 2019 | |
| Mayne Pharma Commercial LLC | $34.11 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $25.71 | 2019 | |
| Abbvie INC. | $21.26 | 2021 | |
| Pfizer INC. | $13.61 | 2019 | |
| Theratechnologies INC. | $12.73 | 2019 | |
| Melinta Therapeutics, LLC | $12.53 | 2019 | |
| Smith+Nephew, INC. | $11.51 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Barbaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.